LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Xilio Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Xilio Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Key Personnel Upgrade Xilio Therapeutics, Inc. recently promoted Chris Frankenfield to Chief Financial Officer, a strategic move that signifies potential shifts in financial strategies and opens up opportunities for new financial partnerships or collaborations.

Board Expansion The addition of experienced professionals like James Shannon and Aoife Brennan to Xilio Therapeutics' board of directors indicates a focus on strengthening leadership and governance, presenting opportunities for network expansion and strategic alliances.

Strategic Funding With recent funding of $3.3 million from Gilead Sciences and a total funding of $11 million, Xilio Therapeutics has the financial backing to explore new research avenues or expand its product pipeline, potentially opening sales opportunities for investors or collaborators.

Immunotherapy Development Xilio Therapeutics' focus on developing tumor-activated immuno-oncology therapies aligns with current market trends and presents opportunities for partnerships with healthcare providers or pharmaceutical companies interested in innovative cancer treatments.

Competitive Positioning In a landscape with similar companies like Revolution Medicines, Celsius Therapeutics, and Jnana Therapeutics, Xilio Therapeutics' revenue range and innovative technology position it as a viable partner for collaborative research ventures or market expansion strategies.

Similar companies to Xilio Therapeutics, Inc.

✕

Access Insights for Xilio Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Xilio Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Xilio Therapeutics, Inc. Tech Stack

Xilio Therapeutics, Inc. uses 8 technology products and services including jsDelivr, CookieYes, SAP, and more. Explore Xilio Therapeutics, Inc.'s tech stack below.

  • jsDelivr
    Content Delivery Network
  • CookieYes
    Cookie Compliance
  • SAP
    Customer Relationship Management
  • Google Font API
    Font Scripts
  • ADP
    Human Resource Management System
  • Microsoft
    Miscellaneous
  • PHP
    Programming Languages
  • Vimeo
    Video Players

Media & News

Xilio Therapeutics, Inc.'s Email Address Formats

Xilio Therapeutics, Inc. uses at least 1 format(s):
Xilio Therapeutics, Inc. Email FormatsExamplePercentage
FLast@xiliotx.comJDoe@xiliotx.com
49%
LFirst@xiliotx.comDJohn@xiliotx.com
1%
FiLast@xiliotx.comJoDoe@xiliotx.com
1%
FLast@xiliotx.comJDoe@xiliotx.com
49%

Frequently Asked Questions

Where is Xilio Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconXilio Therapeutics, Inc.'s main headquarters is located at 828 Winter St Waltham, Massachusetts 02451 US. The company has employees across 2 continents, including North AmericaEurope.

What is Xilio Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Xilio Therapeutics, Inc.'s main corporate office by phone at
✕

Access Insights for Xilio Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Xilio Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-212-899-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Xilio Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign iconXilio Therapeutics, Inc. is a publicly traded company; the company's stock symbol is XLO.

What is Xilio Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconXilio Therapeutics, Inc.'s official website is xiliotx.com and has social profiles on LinkedIn.

How much revenue does Xilio Therapeutics, Inc. generate?

Minus sign iconPlus sign icon As of September 2024, Xilio Therapeutics, Inc.'s annual revenue reached $35M.

What is Xilio Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconXilio Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Xilio Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of September 2024, Xilio Therapeutics, Inc. has approximately 67 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: R. R.Chief Financial Officer And Chief Operating Officer: C. F.Chief Medical Officer: K. L.. Explore Xilio Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Xilio Therapeutics, Inc. belong to?

Minus sign iconPlus sign iconXilio Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Xilio Therapeutics, Inc. use?

Minus sign iconPlus sign iconXilio Therapeutics, Inc.'s tech stack includes jsDelivrCookieYesSAPGoogle Font APIADPMicrosoftPHPVimeo.

What is Xilio Therapeutics, Inc.'s email format?

Minus sign iconPlus sign iconXilio Therapeutics, Inc.'s email format typically follows the pattern of . Find more Xilio Therapeutics, Inc. email formats with LeadIQ.

How much funding has Xilio Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of September 2024, Xilio Therapeutics, Inc. has raised $11M in funding. The last funding round occurred on Mar 28, 2024 for $11M.

When was Xilio Therapeutics, Inc. founded?

Minus sign iconPlus sign iconXilio Therapeutics, Inc. was founded in 2016.
Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.

✕

Access Insights for Xilio Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Xilio Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
828 Winter St Waltham, Massachusetts 02451 US
Phone number
✕

Access Insights for Xilio Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Xilio Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-212-899-****
Website
xiliotx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
XLO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $11M

    Xilio Therapeutics, Inc. has raised a total of $11M of funding over 5 rounds. Their latest funding round was raised on Mar 28, 2024 in the amount of $11M.

  • $10M$50M

    Xilio Therapeutics, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $11M

    Xilio Therapeutics, Inc. has raised a total of $11M of funding over 5 rounds. Their latest funding round was raised on Mar 28, 2024 in the amount of $11M.

  • $10M$50M

    Xilio Therapeutics, Inc.'s revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Xilio Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Xilio Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.